Many productive years in the biologics industry have produced many accomplishments in vaccine design, implementation, testing and acceptance.

Recently:

1. Scale-up of recombinant bacterial and viral vectors. Most recently Sylvatic Plague -Raccoonpox virus.
2. New live bacterial and viral stabilizers.
3. New growth implementation for virus-bearing cell cultures.
4. BSL-2 and BSL-3 lab design and oversight.
5. ABSL-2 audits and CAPA.
6. New challenge models for livestock and laboratory animals.
7. DSP for recombinantly expressed proteins.
8. International regulatory interactions.
9. Improved vaccines for African livestock.